NasdaqCM - Delayed Quote • USD
Check-Cap Ltd. (CHEK)
At close: May 13 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | -0.87 | 0 | -3.25 | -2.59 |
Low Estimate | -0.87 | 0 | -3.25 | -2.59 |
High Estimate | -0.87 | 0 | -3.25 | -2.59 |
Year Ago EPS | -0.63 | -0.76 | -3.37 | -3.25 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
---|---|---|---|---|
EPS Est. | -0.68 | -0.54 | -0.45 | -0.29 |
EPS Actual | -0.63 | -0.76 | -1.18 | -0.44 |
Difference | 0.05 | -0.22 | -0.73 | -0.15 |
Surprise % | 7.40% | -40.70% | -162.20% | -51.70% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Current Estimate | -0.87 | 0 | -3.25 | -2.59 |
7 Days Ago | -0.87 | -0.17 | -3.25 | -2.59 |
30 Days Ago | -0.87 | -0.17 | -3.25 | -2.59 |
60 Days Ago | -0.87 | -0.17 | -3.25 | -2.59 |
90 Days Ago | -0.52 | -0.17 | -2.76 | -1.63 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | CHEK | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -38.10% | -- | -- | 8.30% |
Next Qtr. | -- | -- | -- | 11.90% |
Current Year | 3.60% | -- | -- | 5.60% |
Next Year | 20.30% | -- | -- | 13.00% |
Next 5 Years (per annum) | -- | -- | -- | 11.05% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Downgrade | HC Wainwright & Co.: Buy to Neutral | 6/7/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2023 |
Reiterates | HC Wainwright & Co.: Buy | 4/5/2023 |
Maintains | HC Wainwright & Co.: Buy | 8/9/2021 |
Downgrade | Dawson James: Buy to Neutral | 3/17/2021 |
Maintains | HC Wainwright & Co.: Buy | 3/16/2021 |
Related Tickers
SYAB.DE SYNLAB AG
10.28
+0.39%
HTGMQ HTG Molecular Diagnostics, Inc.
0.0015
-40.00%
CORBF Global Cord Blood Corporation
1.2500
0.00%
BIM.PA bioMérieux S.A.
97.00
-2.32%
SKHCF Sonic Healthcare Limited
18.26
+0.19%
LMDXF LumiraDx Limited
0.0239
-4.40%
OCX OncoCyte Corporation
2.8850
-0.17%
ERF.PA Eurofins Scientific SE
57.40
-0.45%
BIAF bioAffinity Technologies, Inc.
1.9900
-0.50%
TTOO T2 Biosystems, Inc.
4.3900
+18.81%